News World Center

Medical Marijuana Market Size to reach USD 54,677.1 million by the year 2023 with noteworthy CAGR 34.0%

Press release   •   Sep 23, 2019 23:02 EDT

To reach attain USD 54,677.1 million by the year 2023, Global Medical Marijuana Market is predicted to list a CAGR of 34.0%.

The new research from Ameco Research on Global Medical Marijuana Market Report for 2023 intends to offer a target audience with a fresh outlook on the market and fill in the knowledge gaps with the help of processed information and opinions from industry experts. The information in the research report is well-processed and a report is accumulated by industry professionals and seasoned experts in the field to ensure of the quality of research.

The research is backed by extensive and in-depth secondary research which involves reference to various statistical databases, national government documents, relevant patent and regulatory databases, news articles, press releases, company annual reports, webcasts, financial reports, and a number of internal and external proprietary databases. This estimated data is cross-checked with industry experts from various leading companies in the market. After the entire authentication process, these reports are shared with subject matter experts (SMEs) for adding further value and to gain their insightful opinion on the research. With such a robust process of data extraction, verification, and finalization, we firmly endorse the quality of our research. With such extensive and in-depth research and comprehensive coverage of information, it is always a possibility of clients finding their desired information in the report with enclosure of key components and valuable statistics in all regards.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ 
http://www.amecoresearch.com/sample/159595

Global Medical Marijuana Market: Information by Product Type (Solid, Gas and Dissolvable/Powders), Application (Alzheimer's Disease, Cancer, Schizophrenia and Multiple Sclerosis), Distribution Channel (Retail & Pharmacy Stores, Online Platforms) and Region - Forecast till 2023

Market analysis

To reach attain USD 54,677.1 million by the year 2023, Global Medical Marijuana Market is predicted to list a CAGR of 34.0%.
Marijuana is a plant having some chemical composite "cannabis" that has medical property. A number of pharmaceutical companies use this plant as a raw material to manufacture drugs for numerous therapeutic applications. Marijuana plants abstracts are also useful to treat the disease and various conditions caused by the disease such as the central nervous system, cancer, Alzheimer's and used in anti-aging products.
The increasing prevalence of chronic diseases, mounting therapeutic applications of the marijuana plant, rising acceptance of marijuana for medical treatment in many countries, and cumulative authorization of marijuana are predicted to push the market growth. The global medical marijuana market has been mainly driven by the growing research and development activities and financial support by several private and government organizations for cannabinoid research
However, some factors may detain the market growth during the forecast period such as the wide-ranging approval procedures, laborious government policies, and growing illegal use of marijuana.
America held the largest market share in 2017 and the regional market is expected to list a CAGR of 34.0% during the forecast period. Due to the increasing prevalence of Alzheimer disease, cancer, and others American is anticipated to hold the largest market share. Europe is likely to be the second-largest market share, with 5.5% from the global medical marijuana market, and the projected fastest-growing market in Asia-Pacific.
Envisioned Onlookers are Research Institutes and Academic Centers, Pharmaceutical Companies, Market Research and Consulting, Healthcare Providers, Government Associations, Medical Marijuana Manufacturers.

View Detail Report With Complete Table of Content@ http://www.amecoresearch.com/market/global-medical-marijuana-market-2023-159595

Market segmentation

The segmentation is based on 4 parts. The first part is Global Medical Marijuana Market, by Product Type that has been divided into 4 segments i.e. Ointments & Creams, Dissolvable/ Powders, Ointments & creams. Then the second part is Global Medical Marijuana Market, by Application that includes Alzheimer's Disease, Cancer, Schizophrenia, Multiple Sclerosis. The third segmentation is made on Distribution Channel that includes Retail & Pharmacy Stores, Online Platforms, Others. The last segmentation is based on Region that includes Americas covering North America (US, Canada) and South America, Europe covering Western Europe (Germany, UK, France, Italy, Spain, Rest of Western Europe) and Eastern Europe, Asia-Pacific covering China, Japan, India, Australia, South Korea, Rest of Asia-Pacific, Middle East & Africa covering Middle East and Africa.

Regional Analysis

The global medical marijuana market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.


Major Players

Cannabis Sativa Inc (Nevada), GEmerald Health Therapeutics Inc. (Victoria, BC), Tilray (Nanaimo, BC), Canopy Growth Corporation (US), Aphria (Ontario), (Nevada) and MediPharm Labs (US) CanniMed Ltd (Canada), Cara Therapeutics (US), Pfizer Inc. (US), Medical Marijuana Inc (US), GBSciences Inc., W Pharmaceuticals Plc (US), are some of the eminent players in the global medical marijuana market.

Available customization:

With the given market information, Ameco research offers customization's in line with the company's specific wishes. The following customization choices unit of measurement accessible for the report:
Regional and country-level analysis of the Global Medical Marijuana Market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Medical Marijuana Market Research Report Forecast to 2023

1 Report Prologue
2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 List of Assumptions
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growing research and development activities and financial support by various private and government organizations for cannabinoid research
4.2.2 Rising prevalence of chronic diseases and other medical conditions
4.2.3 Increasing authorization of marijuana for medical applications
4.3 Restraints
4.3.1 Stringent government policies
4.3.2 Increasing illegal use of marijuana
4.3.3 Side-effects after the intense use of marijuana
4.4 Challenges
4.4.1 Change in government regulations for the use of cannabis for medical applications
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 Overview
5.1.2 R&D
5.1.3 Manufacturing
5.1.4 Distribution & Sales
5.1.5 Post-Sales Monitoring
5.2 Porter’s Five Forces Model
5.2.1 Overview
5.2.2 Bargaining Power of Suppliers
5.2.3 Bargaining Power of Buyers
5.2.4 Threat of New Entrants
5.2.5 Threat of Substitutes
5.2.6 Intensity of Rivalry
6 Global Medical Marijuana Market, by Product Type
6.1 Introduction
6.2 Solids
6.3 Dissolvables/Powders
6.4 Oil
6.5 Ointments & Creams
7 Global Medical Marijuana Market, by Application
7.1 Introduction
7.2 Alzheimer’s Disease
7.3 Cancer
7.4 Schizophrenia
7.5 Multiple Sclerosis
8 Global Medical Marijuana Market, by Distribution Channel
8.1 Introduction
8.2 Retail & Pharmacy Stores
8.3 Online Platforms
9 Global Medical Marijuana Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 UK
9.3.1.3 France
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia-Pacific
9.5 Rest of the World
10 Competitive Landscape
11 Company Profile
11.1 Canopy Growth Corporation
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products/Services Offered
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.1.6 Key Strategy
11.2 Cannabis Sativa Inc.
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products/Services Offered
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.2.6 Key Strategy
11.3 GW Pharmaceuticals Plc
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products/Services Offered
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.3.6 Key Strategy
11.4 Emerald Health Therapeutics Inc.
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products/Services Offered
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.4.6 Key Strategy
11.5 Tilray
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products/Services Offered
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.5.6 Key Strategy
11.6 Aphria
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products/Services Offered
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategy
11.7 CanniMed Ltd
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products/Services Offered
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.7.6 Key Strategy
11.8 Cara Therapeutics
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Pipeline Products
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.8.6 Key Strategy
11.9 Pfizer Inc.
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Clinical Trial Products
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.9.6 Key Strategy
11.1 Medical Marijuana Inc.
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products/Services Offered
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.10.6 Key Strategy
11.11 GBSciences Inc.
11.11.1 Company Overview
11.11.2 Financial Overview
11.11.3 Pipeline Products
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.11.6 Key Strategy
11.12 MediPharm Labs
11.12.1 Company Overview
11.12.2 Financial Overview
11.12.3 Products/Services Offered
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.12.6 Key Strategy
12 Appendix
12.1 Discussion Blue Print

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/159595

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decisions by understanding their requirements and suggesting the best possible collection matching their needs.

Contact:
Email: sales@amecoresearch.com| Call: + 1 407 915 4157